IP Library Granted Patent US 10,633,481
Granted Patent B2
US 10,633,481 · App. 14/635,472 · Granted Apr 28, 2020

Polyurea systems, processes for preparing the same and use thereof for postoperative adhesion barriers

Inventors: Heike Heckroth (Odenthal, DE); Hartmut Nefzger (Pulheim, DE); Christian Wamprecht (Neuss, DE)
Assignee: Adhesys Medical GmbH
C08G18/3821A61L15/26A61L31/06A61L31/148C08G18/10C08G18/3262C08G18/4252C08G18/485C08G18/4841C08G18/73C08G18/7621A61L2430/00Y10T428/31551Y10T428/31594
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,633,481
App. No.
14/635,472
Granted
Apr 28, 2020
Kind
B2
Abstract

Polyurea systems comprising: (a) an amino-functional aspartic ester of the general formula (I) wherein X represents an n-valent organic radical derived from a corresponding n-functional primary amine X(NH 2 ) n , R 1 and R 2 each independently represent an organic radical having no Zerevitinov active hydrogens and n represents an integer of at least 2; and (b) an isocyanate functional prepolymer having a residual monomer content of less than 1% by weight, the prepolymer prepared by reacting: (b1) an aliphatic isocyante; and (b2) a polyol component having a number average molecular weight of ≥400 g/mol and an average OH functionality of 2 to 6, wherein the polyol component comprises one or more constituents selected from the group consisting of polyester polyols, polyester-polyether polyols and mixtures thereof; processes for making the same; postoperative adhesions barriers prepared therewith and dispensing systems for such polyurea systems.

Claims (49)

1. A polyurea system comprising:

(a) an amino-functional aspartic ester of the general formula (I)

wherein

X is an n-valent organic radical having 2 to 5 carbon atoms,

R 1 and R 2 each independently represent an organic radical having no Zerevitinov active hydrogens and n represents an integer of at least 2;

(b) an isocyanate functional prepolymer having a residual monomer content of less than 1% by weight, the prepolymer prepared by reacting:

(b1) an aliphatic isocyante; and

(b2) a polyol component comprising:

a polyether polyol which has a number-average molecular weight of 100 to 2,000 g/mol; and

a polyol component comprising one or more constituents selected from the group consisting of polyester polyols, polyester-polyether polyols and mixtures thereof having a number average molecular weight of ≥400 g/mol and an average OH functionality of 2 to 6;

wherein the ether groups are derived from, 60% to 90% of ethylene oxide units, based on the amounts of alkylene oxide units that are present in total,

(c) an organic filler comprising a hydroxy-functional polyether polyol compound having a DIN 53019 viscosity at 23° C. of 10 to 6000 mPas, and

wherein the ratio of free or blocked amino groups to free NCO groups is about 1:1.

2. The polyurea system according to claim 1 , further comprising: (d) a reaction product of an isocyanate functional prepolymer according to (b) and an amino-functional aspartic ester according to (a).

3. The polyurea system according to claim 1 , further comprising: (d) a reaction product of an isocyanate functional prepolymer according to (b); an amino-functional aspartic ester according to (a); and (c) an organic filler having a DIN 53019 viscosity at 23° C. of 10 to 6000 mPas.

4. The polyurea system according to claim 1 , wherein the polyol component has a hydroxyl number of 30 to 140 mg KOH/g, an acid number of 0.05 to 10 mg KOH/g and a DIN 53019 shear viscosity at 23° C. of 200 to 8000 mPas.

5. The polyurea system according to claim 1 , wherein the polyol component comprises ≤50% by weight of polyether polyols based on the polyol component.

6. The polyurea system according to claim 1 , wherein the polyol component has an ester group concentrations of 0.5 to 5.5 moles per kg.

7. The polyurea system according to claim 1 , further comprising: (d) a reaction product of an isocyanate functional prepolymer according to (b) and an amino-functional aspartic ester according to (a); wherein the polyol component has a hydroxyl number of 30 to 140 mg KOH/g, an acid number of 0.05 to 10 mg KOH/g and a DIN 53019 shear viscosity at 23° C. of 200 to 8000 mPas; wherein the polyol component comprises ≤50% by weight of polyether polyols based on the polyol component.

8. The polyurea system according to claim 1 , wherein the weight ratio of the organic filler (c) to the amino-functional aspartic ester component (a) is from 0:1 to 12:1.

9. A process for preparing a polyurea system, the process comprising:

(i) providing (a) an amino-functional aspartic ester of the general formula (I)

wherein

X is an n-valent organic radical having 2 to 5 carbon atoms,

R 1 and R 2 each independently represent an organic radical having no Zerevitinov active hydrogens and n represents an integer of at least 2;

(ii) providing (b) an isocyanate functional prepolymer having a residual monomer content of less than 1% by weight, the prepolymer prepared by reacting:

(b1) an aliphatic isocyante; and

(b2) a polyol component comprising:

a polyether polyol which has a number-average molecular weight of 100 to 2,000 g/mol; and

a polyol component comprising one or more constituents selected from the group consisting of polyester polyols, polyester-polyether polyols and mixtures thereof having a number average molecular weight of ≥400 g/mol and an average OH functionality of 2 to 6;

wherein the ether groups are derived from, 60% to 90% of ethylene oxide units, based on the amounts of alkylene oxide units that are present in total;

(iii) providing (c) an organic filler comprising a hydroxy-functional polyether polyol compound having a DIN 53019 viscosity at 23° C. of 10 to 6000 mPas; and wherein the (c) organic filler is mixed with the (a) amino-functional aspartic ester and the (b) isocyanate functional prepolymer at a weight ratio of organic filler to amino-functional aspartic ester of 0:1 to 20:1; and

(iv) mixing the (a) amino-functional aspartic ester and the (b) isocyanate functional prepolymer in a ratio of free or blocked amino groups to free NCO groups of 1:1.

10. A polyurea system prepared according to the process of claim 9 .

11. A method comprising:

(i) providing cell tissue to be treated;

(ii) providing a polyurea system according to claim 1 ; and

(iii) contacting the cell tissue to be treated with the polyurea system.

12. A post operative adhesion barrier comprising a polyurea system according to claim 1 .

13. A film comprising a polyurea system according to claim 1 .

14. A dispensing system comprising a first chamber and a second chamber; wherein the first chamber comprises (a) an amino-functional aspartic ester of the general formula (I)

wherein

X is an n-valent organic optionally branched or cyclic organic radical having 2 to 5 carbon atoms,

R 1 and R 2 each independently represent an organic radical having no Zerevitinov active hydrogens and n represents an integer of at least 2; and wherein the second chamber comprises (b) an isocyanate functional prepolymer having a residual monomer content of less than 1% by weight, the prepolymer prepared by reacting:

(b1) an aliphatic isocyante; and

(b2) a polyol component comprising:

a polyether polyol which has a number-average molecular weight of 100 to 2,000 g/mol; and

a polyol component comprising one or more constituents selected from the group consisting of polyester polyols, polyester-polyether polyols and mixtures thereof having a number average molecular weight of ≥400 g/mol and an average OH functionality of 2 to 6;

wherein the ether groups are derived from, 60% to 90% of ethylene oxide units, based on the amounts of alkylene oxide units that are present in total.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT APPL. NO. 13/369,744 PREVIOUSLY RECORDED AT REEL: 038810 FRAME: 0860. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Jul 21, 2016
From: MEDICAL ADHESIVE REVOLUTION GMBH
To: ADHESYS MEDICAL GMBH
Reel/Frame 039427/0230 →
CHANGE OF NAME Recorded May 25, 2016
From: MEDICAL ADHESIVE REVOLUTION GMBH
To: ADHESYS MEDICAL GMBH
Reel/Frame 038810/0860 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2015
From: BAYER MATERIALSCIENCE AG
To: MEDICAL ADHESIVE REVOLUTION GMBH
Reel/Frame 035126/0859 →
Priority Claims (1)
EP 08003620 · Feb 28, 2008 · regional
Continuity (2)
Continuation 12370639 · Feb 13, 2009
Related Publication 20150166715A1 · Jun 18, 2015